View Past PerformanceSpigen KoreaLtd バランスシートの健全性財務の健全性 基準チェック /56Spigen KoreaLtdの総株主資本は₩552.1B 、総負債は₩10.6Bで、負債比率は1.9%となります。総資産と総負債はそれぞれ₩597.1Bと₩45.0Bです。 Spigen KoreaLtdの EBIT は₩33.2Bで、利息カバレッジ比率-6です。現金および短期投資は₩190.1Bです。主要情報1.92%負債資本比率₩10.58b負債インタレスト・カバレッジ・レシオ-6x現金₩190.13bエクイティ₩552.08b負債合計₩45.01b総資産₩597.09b財務の健全性に関する最新情報分析記事 • Jun 12Is Spigen KoreaLtd (KOSDAQ:192440) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Feb 02Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jun 08Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩29,000, the stock trades at a trailing P/E ratio of 5x. Average trailing P/E is 6x in the Tech industry in South Korea. Total loss to shareholders of 11% over the past three years.Valuation Update With 7 Day Price Move • May 18Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩30,100, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 2.7% over the past three years.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩27,100, the stock trades at a trailing P/E ratio of 5.6x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 8.5% over the past three years.お知らせ • Mar 17Spigen Korea Co.,Ltd, Annual General Meeting, Mar 30, 2026Spigen Korea Co.,Ltd, Annual General Meeting, Mar 30, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 446, bongeunsa-ro, gangnam-gu, seoul South KoreaNew Risk • Sep 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩138.1b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₩138.1b market cap, or US$99.1m).分析記事 • Jun 12Is Spigen KoreaLtd (KOSDAQ:192440) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩28,950, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 7x in the Tech industry in South Korea. Total loss to shareholders of 19% over the past three years.Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩27,500, the stock trades at a trailing P/E ratio of 5.7x. Average trailing P/E is 19x in the Tech industry in South Korea. Total loss to shareholders of 35% over the past three years.New Risk • Mar 14New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.2% Last year net profit margin: 9.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 10% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.2% net profit margin).お知らせ • Mar 13Spigen Korea Co.,Ltd, Annual General Meeting, Mar 27, 2025Spigen Korea Co.,Ltd, Annual General Meeting, Mar 27, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 446, bongeunsa-ro, gangnam-gu, seoul South Korea分析記事 • Mar 10Spigen Korea Co.,Ltd's (KOSDAQ:192440) Shares Bounce 26% But Its Business Still Trails The MarketSpigen Korea Co.,Ltd ( KOSDAQ:192440 ) shares have continued their recent momentum with a 26% gain in the last month...Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩24,350, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 41% over the past three years.分析記事 • Jan 10Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share Price Is Matching Sentiment Around Its EarningsWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 12x, you may consider Spigen...New Risk • Dec 07New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2021. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩115.7b market cap, or US$81.3m).New Risk • Oct 14New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩135.4b (US$99.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.2% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₩135.4b market cap, or US$99.6m).New Risk • Aug 30New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 10% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.2% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.1% net profit margin).分析記事 • Aug 08Earnings Working Against Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share PriceWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 12x, you may consider Spigen...Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Outside Director Hee-Yeon Seon Woo was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.New Risk • Mar 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 28% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 2.8% per year over the past 5 years. High level of non-cash earnings (28% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.Upcoming Dividend • Dec 20Upcoming dividend of ₩560 per share at 1.8% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 18 April 2024. Payout ratio is a comfortable 9.7% but the company is not cash flow positive. Trailing yield: 1.8%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (2.0%).Upcoming Dividend • Dec 21Upcoming dividend of ₩840 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 12% but the company is paying out more than the cash it is generating. Trailing yield: 2.5%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.5%).Buying Opportunity • Jan 25Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 13%. The fair value is estimated to be ₩51,010, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% per annum over the last 3 years. Earnings per share has grown by 6.7% per annum over the last 3 years.Upcoming Dividend • Dec 22Upcoming dividend of ₩1,200 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 2.9%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.9%).分析記事 • Apr 13Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In ValueWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...分析記事 • Mar 30Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?Is Spigen Korea Co., Ltd. ( KOSDAQ:192440 ) a good dividend stock? How can we tell? Dividend paying companies with...Reported Earnings • Mar 24Full year 2020 earnings releasedThe company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: ₩403.3b (up 31% from FY 2019). Net income: ₩54.8b (up 36% from FY 2019). Profit margin: 14% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 7% per year.分析記事 • Mar 15Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?With its stock down 4.3% over the past three months, it is easy to disregard Spigen Korea (KOSDAQ:192440). However...分析記事 • Mar 01Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?A look at the shareholders of Spigen Korea Co., Ltd. ( KOSDAQ:192440 ) can tell us which group is most powerful...Is New 90 Day High Low • Feb 24New 90-day low: ₩61,500The company is down 4.0% from its price of ₩64,000 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩161,841 per share.分析記事 • Feb 16Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price GainThe main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...分析記事 • Feb 02Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Jan 20Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...分析記事 • Jan 07What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...分析記事 • Dec 25Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Spigen Korea...分析記事 • Dec 14Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?With its stock down 17% over the past three months, it is easy to disregard Spigen Korea (KOSDAQ:192440). However...分析記事 • Dec 01Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?A look at the shareholders of Spigen Korea Co., Ltd. ( KOSDAQ:192440 ) can tell us which group is most powerful...Reported Earnings • Nov 22Third quarter 2020 earnings released: EPS ₩5,167The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₩144.3b (up 73% from 3Q 2019). Net income: ₩31.2b (up 166% from 3Q 2019). Profit margin: 22% (up from 14% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 9% per year.分析記事 • Nov 17Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?As a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...財務状況分析短期負債: A192440の 短期資産 ( ₩302.3B ) が 短期負債 ( ₩33.5B ) を超えています。長期負債: A192440の短期資産 ( ₩302.3B ) が 長期負債 ( ₩11.5B ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: A192440総負債よりも多くの現金を保有しています。負債の削減: A192440の負債対資本比率は、過去 5 年間で1.6%から1.9%に増加しました。債務返済能力: A192440の負債は 営業キャッシュフロー によって 十分にカバー されています ( 482.9% )。インタレストカバレッジ: A192440支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YTech 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/31 10:34終値2026/07/31 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Spigen Korea Co.,Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Kevin SeoCitigroup IncKyung-rae HanDaishin Securities Co. Ltd.Eun-Jeong SongiM Securities8 その他のアナリストを表示
分析記事 • Jun 12Is Spigen KoreaLtd (KOSDAQ:192440) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Feb 02Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩29,000, the stock trades at a trailing P/E ratio of 5x. Average trailing P/E is 6x in the Tech industry in South Korea. Total loss to shareholders of 11% over the past three years.
Valuation Update With 7 Day Price Move • May 18Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩30,100, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 2.7% over the past three years.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩27,100, the stock trades at a trailing P/E ratio of 5.6x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 8.5% over the past three years.
お知らせ • Mar 17Spigen Korea Co.,Ltd, Annual General Meeting, Mar 30, 2026Spigen Korea Co.,Ltd, Annual General Meeting, Mar 30, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 446, bongeunsa-ro, gangnam-gu, seoul South Korea
New Risk • Sep 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩138.1b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₩138.1b market cap, or US$99.1m).
分析記事 • Jun 12Is Spigen KoreaLtd (KOSDAQ:192440) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩28,950, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 7x in the Tech industry in South Korea. Total loss to shareholders of 19% over the past three years.
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩27,500, the stock trades at a trailing P/E ratio of 5.7x. Average trailing P/E is 19x in the Tech industry in South Korea. Total loss to shareholders of 35% over the past three years.
New Risk • Mar 14New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.2% Last year net profit margin: 9.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 10% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.2% net profit margin).
お知らせ • Mar 13Spigen Korea Co.,Ltd, Annual General Meeting, Mar 27, 2025Spigen Korea Co.,Ltd, Annual General Meeting, Mar 27, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 446, bongeunsa-ro, gangnam-gu, seoul South Korea
分析記事 • Mar 10Spigen Korea Co.,Ltd's (KOSDAQ:192440) Shares Bounce 26% But Its Business Still Trails The MarketSpigen Korea Co.,Ltd ( KOSDAQ:192440 ) shares have continued their recent momentum with a 26% gain in the last month...
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩24,350, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 41% over the past three years.
分析記事 • Jan 10Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share Price Is Matching Sentiment Around Its EarningsWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 12x, you may consider Spigen...
New Risk • Dec 07New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2021. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩115.7b market cap, or US$81.3m).
New Risk • Oct 14New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩135.4b (US$99.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.2% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₩135.4b market cap, or US$99.6m).
New Risk • Aug 30New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 10% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.2% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.1% net profit margin).
分析記事 • Aug 08Earnings Working Against Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share PriceWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 12x, you may consider Spigen...
Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Outside Director Hee-Yeon Seon Woo was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
New Risk • Mar 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 28% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 2.8% per year over the past 5 years. High level of non-cash earnings (28% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.
Upcoming Dividend • Dec 20Upcoming dividend of ₩560 per share at 1.8% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 18 April 2024. Payout ratio is a comfortable 9.7% but the company is not cash flow positive. Trailing yield: 1.8%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (2.0%).
Upcoming Dividend • Dec 21Upcoming dividend of ₩840 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 12% but the company is paying out more than the cash it is generating. Trailing yield: 2.5%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.5%).
Buying Opportunity • Jan 25Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 13%. The fair value is estimated to be ₩51,010, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% per annum over the last 3 years. Earnings per share has grown by 6.7% per annum over the last 3 years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩1,200 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 2.9%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.9%).
分析記事 • Apr 13Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In ValueWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
分析記事 • Mar 30Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?Is Spigen Korea Co., Ltd. ( KOSDAQ:192440 ) a good dividend stock? How can we tell? Dividend paying companies with...
Reported Earnings • Mar 24Full year 2020 earnings releasedThe company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: ₩403.3b (up 31% from FY 2019). Net income: ₩54.8b (up 36% from FY 2019). Profit margin: 14% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 7% per year.
分析記事 • Mar 15Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?With its stock down 4.3% over the past three months, it is easy to disregard Spigen Korea (KOSDAQ:192440). However...
分析記事 • Mar 01Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?A look at the shareholders of Spigen Korea Co., Ltd. ( KOSDAQ:192440 ) can tell us which group is most powerful...
Is New 90 Day High Low • Feb 24New 90-day low: ₩61,500The company is down 4.0% from its price of ₩64,000 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩161,841 per share.
分析記事 • Feb 16Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price GainThe main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...
分析記事 • Feb 02Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Jan 20Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
分析記事 • Jan 07What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
分析記事 • Dec 25Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Spigen Korea...
分析記事 • Dec 14Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?With its stock down 17% over the past three months, it is easy to disregard Spigen Korea (KOSDAQ:192440). However...
分析記事 • Dec 01Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?A look at the shareholders of Spigen Korea Co., Ltd. ( KOSDAQ:192440 ) can tell us which group is most powerful...
Reported Earnings • Nov 22Third quarter 2020 earnings released: EPS ₩5,167The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₩144.3b (up 73% from 3Q 2019). Net income: ₩31.2b (up 166% from 3Q 2019). Profit margin: 22% (up from 14% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 9% per year.
分析記事 • Nov 17Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?As a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...